Insider · CIK 0001201041

LOVE RICHARD L

Reports to the SEC for 4 companies · SEATTLE, WA

sec.gov

Transactions

Companies

Filings

CIK

0001201041

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2017-09-29	PAREXEL INTERNATIONAL CORPD Disposition to Issuer	Director	DDisposition to Issuer	−88.3K sh	—	—	0
2017-09-29	CTI BIOPHARMA CORPS Sale	Director	SSale	−976 sh	$3.20	−$3,123.2	73,718
2017-09-28	CTI BIOPHARMA CORPS Sale	Director	SSale	−477 sh	$3.24	−$1,545.48	74,894
2017-09-28	CTI BIOPHARMA CORPS Sale	Director	SSale	−2,747 sh	$3.20	−$8,790.4	80,871
2017-09-28	CTI BIOPHARMA CORPS Sale	Director	SSale	−1,000 sh	$3.21	−$3,210	79,571
2017-09-28	CTI BIOPHARMA CORPS Sale	Director	SSale	−200 sh	$3.25	−$650	74,694
2017-09-28	CTI BIOPHARMA CORPS Sale	Director	SSale	−600 sh	$3.22	−$1,932	78,871
2017-09-28	CTI BIOPHARMA CORPS Sale	Director	SSale	−1,675 sh	$3.23	−$5,410.25	77,171
2017-09-28	CTI BIOPHARMA CORPS Sale	Director	SSale	−4,000 sh	$3.19	−$12.8K	84,318
2017-09-28	CTI BIOPHARMA CORPS Sale	Director	SSale	−100 sh	$3.21	−$320.75	80,571
2017-09-28	CTI BIOPHARMA CORPS Sale	Director	SSale	−700 sh	$3.19	−$2,236.5	83,618
2017-09-28	CTI BIOPHARMA CORPS Sale	Director	SSale	−100 sh	$3.21	−$321.5	79,471
2017-09-28	CTI BIOPHARMA CORPS Sale	Director	SSale	−200 sh	$3.21	−$641	80,671
2017-09-28	CTI BIOPHARMA CORPS Sale	Director	SSale	−1,600 sh	$3.23	−$5,168.16	75,571
2017-09-28	CTI BIOPHARMA CORPS Sale	Director	SSale	−200 sh	$3.23	−$647	75,371
2017-09-28	CTI BIOPHARMA CORPS Sale	Director	SSale	−25 sh	$3.23	−$80.625	78,846
2017-09-20	CTI BIOPHARMA CORPStock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2017-09-08	PAREXEL INTERNATIONAL CORPA Award	Director	AAward	+1,823 sh	—	—	88,302
2017-04-29	CTI BIOPHARMA CORPM Exercise/Conversion	Director	MExercise/Conversion	+34.7K sh	—	—	88,318
2017-04-29	CTI BIOPHARMA CORPRestricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−34.7K sh	—	—	0
2016-10-20	CTI BIOPHARMA CORPEmployee Stock Option (Right to Buy)A Award	Director	AAward	+500K sh	—	—	500,000
2016-10-20	CTI BIOPHARMA CORPEmployee Stock Option (Right to Buy)A Award	Director	AAward	+500K sh	—	—	500,000
2016-09-15	PAREXEL INTERNATIONAL CORPA Award	Director	AAward	+2,369 sh	—	—	86,479
2016-04-29	CTI BIOPHARMA CORPRestricted Stock UnitA Award	Director	AAward	+347K sh	—	—	347,360
2016-04-29	CTI BIOPHARMA CORPRestricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−63.7K sh	—	—	0
2016-04-29	CTI BIOPHARMA CORPM Exercise/Conversion	Director	MExercise/Conversion	+63.7K sh	—	—	535,824
2016-03-30	PAREXEL INTERNATIONAL CORPS Sale	Director	SSale	−1,330 sh	$62.50	−$83.1K	84,110
2015-12-29	CTI BIOPHARMA CORPStock Option (right to buy)A Award	Director	AAward	+100K sh	—	—	100,000
2015-12-10	CTI BIOPHARMA CORPD Disposition to Issuer	Director	DDisposition to Issuer	−58.3K sh	—	—	472,129
2015-12-01	PAREXEL INTERNATIONAL CORPS Sale	Director	SSale	−1,330 sh	$68.21	−$90.7K	85,440
2015-09-30	CTI BIOPHARMA CORPS Sale	Director	SSale	−700 sh	$1.46	−$1,020.53	532,749
2015-09-30	CTI BIOPHARMA CORPS Sale	Director	SSale	−100 sh	$1.46	−$145.75	533,449
2015-09-30	CTI BIOPHARMA CORPS Sale	Director	SSale	−3,149 sh	$1.46	−$4,581.795	533,549
2015-09-30	CTI BIOPHARMA CORPS Sale	Director	SSale	−7,411 sh	$1.45	−$10.7K	536,698
2015-09-30	CTI BIOPHARMA CORPS Sale	Director	SSale	−100 sh	$1.47	−$146.5	530,449
2015-09-30	CTI BIOPHARMA CORPS Sale	Director	SSale	−2,200 sh	$1.46	−$3,212	530,549
2015-09-23	CTI BIOPHARMA CORPRestricted Stock UnitsA Award	Director	AAward	+63.7K sh	—	—	63,695
2015-09-10	PAREXEL INTERNATIONAL CORPA Award	Director	AAward	+2,420 sh	—	—	86,770
2015-09-01	PAREXEL INTERNATIONAL CORPS Sale	Director	SSale	−1,330 sh	$64.26	−$85.5K	84,350
2015-05-14	PAREXEL INTERNATIONAL CORPS Sale	Director	SSale	−5,000 sh	$65.00	−$325K	85,680
2014-09-11	PAREXEL INTERNATIONAL CORPA Award	Director	AAward	+2,662 sh	—	—	90,680
2014-08-11	PAREXEL INTERNATIONAL CORPS Sale	Director	SSale	−6,000 sh	$57.33	−$344K	88,018
2014-03-07	CTI BIOPHARMA CORPS Sale	Director	SSale	−400 sh	$3.75	−$1,502	537,365
2014-03-07	CTI BIOPHARMA CORPS Sale	Director	SSale	−2,964 sh	$3.78	−$11.2K	519,465
2014-03-07	CTI BIOPHARMA CORPS Sale	Director	SSale	−1,400 sh	$3.76	−$5,264	535,965
2014-03-07	CTI BIOPHARMA CORPS Sale	Director	SSale	−700 sh	$3.77	−$2,635.5	535,265
2014-03-07	CTI BIOPHARMA CORPS Sale	Director	SSale	−5,112 sh	$3.77	−$19.3K	528,365
2014-03-07	CTI BIOPHARMA CORPS Sale	Director	SSale	−1,788 sh	$3.77	−$6,733.608	533,477
2014-03-07	CTI BIOPHARMA CORPS Sale	Director	SSale	−11.5K sh	$3.75	−$43.1K	537,765
2014-03-07	CTI BIOPHARMA CORPS Sale	Director	SSale	−2,000 sh	$3.77	−$7,542	526,365

Recent filings

Accepted (ET)
Oct 44
LOVE RICHARD L0000899243-17-023636
SEC(opens sec.gov)
Oct 24
LOVE RICHARD L0000891293-17-000104
SEC(opens sec.gov)
Sep 224
LOVE RICHARD L0000899243-17-022443
SEC(opens sec.gov)
Sep 114
LOVE RICHARD L0001127602-17-027246
SEC(opens sec.gov)
May 24
CTI BIOPHARMA CORP0000899243-17-011489
SEC(opens sec.gov)

Companies

Address

501 ELLIOTT AVE WEST SUITE 400

SEATTLE, WA, 98119